Patent · US Active

Acylnucleoside phosphonates, prodrugs thereof and use thereof as medicament

US11299506B2 · kind B2 · utility

0Cited by
1References
13Claims
0Family size

Assignees

Inventors

Key dates

Filing dateMar 21, 2018
Grant dateApr 12, 2022
Priority date
Expiry dateMar 21, 2038

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Chemical compounds are provided belonging to the group of nucleotide analogues. More specifically, acylnucleoside phosphonate compounds are disclosed and also their method of preparation and their use as medicaments, in particular for the prevention and/or the treatment of diseases caused by infection by an organism that is auxotrophic for purines, such as Plasmodium falciparum. Also disclosed are pharmaceutical compositions containing such compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.